Stocktoria
Corbus Pharmaceuticals Holdings, Inc. CRBP
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2014-10-24
Corbus Pharmaceuticals Holdings, Inc. statistics & valuation
Market cap$161.9M
P / B1.1×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | — | — | — | — | -6350.1% |
| Net margin | — | — | — | — | -5176.4% |
| FCF margin | — | — | — | — | -5471.0% |
| Return on assets | -46.7% | -25.8% | -157.8% | -63.9% | -42.4% |
| Return on equity | -53.2% | -28.2% | 646.0% | -128.4% | -66.0% |
| Debt / equity | — | — | -2.59× | 0.65× | 0.31× |
| Current ratio | 8.07 | 12.94 | 0.74 | 4.76 | 5.89 |
| Revenue growth | — | — | — | -100.0% | -77.6% |
Source: SEC EDGAR filings · CIK 0001595097 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.